17-19343331-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_015681.6(B9D1):c.603C>A(p.Ser201Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,614,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015681.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B9D1 | NM_015681.6 | c.603C>A | p.Ser201Arg | missense_variant | 7/7 | ENST00000261499.11 | NP_056496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B9D1 | ENST00000261499.11 | c.603C>A | p.Ser201Arg | missense_variant | 7/7 | 1 | NM_015681.6 | ENSP00000261499.4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251398Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135880
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461854Hom.: 0 Cov.: 29 AF XY: 0.0000316 AC XY: 23AN XY: 727236
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74492
ClinVar
Submissions by phenotype
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 26, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with B9D1-related conditions. This variant is present in population databases (rs547869203, ExAC 0.07%). This sequence change replaces serine with arginine at codon 201 of the B9D1 protein (p.Ser201Arg). The serine residue is weakly conserved and there is a moderate physicochemical difference between serine and arginine. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2023 | The c.603C>A (p.S201R) alteration is located in exon 7 (coding exon 7) of the B9D1 gene. This alteration results from a C to A substitution at nucleotide position 603, causing the serine (S) at amino acid position 201 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at